Login
|
Register
News
Videos
Insights
Peer Exchange
OncNurse TV
Resources
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancers
Supportive Care
Blood Cancers
Prevention
Genetics
Nurse Navigation
Immuno-Oncology
Drug Safety
Skin Cancer/Melanoma
Brain Cancer
Childhood/AYA Cancer
Head and Neck Cancers
Adverse Event Management
Contributors
Conferences
Partners
Advocacy
Associations
Schools of Nursing
Publications
CE
Blood Cancers
Moving Towards Precision Medicine in MCL
BY NICHOLE TUCKER
RMAT Designation Granted to CT053 CAR T-Cell Therapy By FDA
BY GINA COLUMBUS
Utilizing MRD To Treat Patients With Hairy Cell Leukemia
BY CONOR KILLMURRAY
Expert Identifies Potential Biomarkers for Hairy Cell Leukemia
BY JAMES BLACHLY, MD
Measurable Residual Disease's Role in the Relapse Setting
BY FRAHAD RAVANDI-KASHANI, MD
Addressing the Unmet Needs of Patients with Hairy Cell Leukemia
BY KERRY ROGERS, MD
Expert Discusses the Safety of Vemurafenib
BY AGNIESZKA JANUS, MD, PHD
Managing Toxicities Of Moxetumomab Pasudotox
BY ROBERT J. KREITMAN, MD
FDA Updates Romiplostim Label For ITP Treatment
BY JASON M. BRODERICK
Cancer-Related Cognitive Impairment or Old Age?
BY BRIELLE BENYON
<< Prev Page
Next Page >>
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources
Newsroom
Continuing Education
Discussions
Web Exclusives
About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.